Updates on osteoporosis treatment: Addressing the unmet needs among high-risk postmenopausal osteoporosis patients
The Fracture Liaison Service at Queen Elizabeth Hospital: A 3-year review
Current treatment landscape of psoriatic arthritis and future expectations
Until this year, parathyroid hormone and its related protein analogues were the only recommended anabolic agents for postmenopausal osteoporosis patients with multiple fractures.1 Patients who are contraindicated to the treatment or those who cannot tolerate frequent injections should be switched to
Dr. Woo, Yu-Cho
Honorary Clinical Associate Professor, Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong
In western countries, psoriatic arthritis (PsA) is observed in about 20–30% of patients with psoriasis.1 In Hong Kong, the estimated prevalence rate of psoriasis is around 0.3%-0.6% and there was over 20,000 patients suffering from psoriasis as of 2015.2
Prof. Tam, Lai-Shan
Head, Division of Rheumatology Professor, Department of Medicine & Therapeutics, The Chinese University of Hong Kong
EULAR 2020
From 3 June 2020 |
Virtual
The 3-year review of Fracture Liaison Service (FLS) at Queen Elizabeth Hospital (QEH) depicted its effectiveness in preventing secondary Fragility Hip Fracture (FHF), demonstrating a clinically feasible service model. The caregiver education session included in the FLS improved the quality
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases 2020
Fracture liaison services in Hong Kong: A 3-year review K L Tiu, S M Tam, K H T Chui, K B Lee, W Li
Methotrexate is more hepatotoxic to patients with psoriatic disorders than those with rheumatoid arthritis
Methotrexate is a multi-acting systemic antipsoriatic drug which simultaneously inhibits purine and pyrimidine synthesis, nitric oxide production and the transcription factor nuclear-factor kappa B (NFĸB) which is an inducible transcription factor for the production of pro-inflammatory cytokines and
Rheumatoid arthritis is associated with an increased risk of heart failure
The burden of heart failure (HF) is increasing worldwide.1 Cardiovascular disease (CVD) risk scores have identified rheumatoid arthritis (RA) patients to be at higher risk of developing HF.2
Heat and gut microbiota promotes stronger bones
